In this episode of The Rob & Jai Show, Michael O’Rourke, CEO of Re-Vana Therapeutics, joins Dr. Rob Rothman and Dr. Jai Parekh to explore the next-generation of sustained drug delivery in ophthalmology. With millions of intravitreal injections administered annually for retinal diseases like AMD, the need for longer-lasting, more effective treatments has never been greater. O’Rourke explains how Re-Vana’s proprietary hydrogel-based technologies are setting a new standard for biodegradable, sustained-release drug implants—offering six to twelve months of therapeutic coverage without the need ..read more

In this episode of The Rob & Jai Show, Dr. Rob Rothman and Dr. Jai Parekh host a captivating conversation with Andrew Stewart and Anthony Wallace—two leaders who are among the most experienced and admired executives in ophthalmology. Andrew Stewart, with over 25 years of pharmaceutical leadership across Bausch + Lomb, AbbVie, and Allergan, shares how his global business acumen shapes innovation in eye care. Anthony Wallace, a 26-year healthcare veteran with leadership roles at Novartis, Merck, and GlaxoSmithKline, reflects on leading Bausch + Lomb’s U.S. Surgical business and his passion f ..read more

In this OIS Podcast episode, host Dr. Robert Rothman sits down with Daphne Haim-Langford, PhD, Founder & CEO of Tarsier Pharma, and Ashley Kline, Chief Commercial Officer, to discuss their groundbreaking approach to uveitis treatment. Tarsier’s lead candidate, TRS01, is a first-in-class bio-inspired therapy designed to control inflammation without raising intraocular pressure, a major complication of steroid treatments. With a unique mechanism of action that modulates macrophages and reduces inflammation, this novel drug has the potential to redefine uveitis and glaucoma care.   In th ..read more

In this episode of Eye on Innovation, host Carey Powers introduces the Next-Gen Innovators series with special guest Dr. Vikram Shankar, an ophthalmologist at Stanford and co-founder of Dropmate. Dr. Shankar discusses how his passion for public health and patient care inspired the creation of Dropmate—a compact, affordable, and eco-friendly disinfection system for clinical eye care equipment. Learn how this technology addresses patient safety, cost savings, and environmental sustainability, all while transforming the standard of care in ophthalmology. In this episode, you’ll learn: How Dropma ..read more

In this episode of The Rob and Jai Show, Dave LeCause, a renowned biopharmaceutical leader and former VP of Allergan Eye Care, reflects on his remarkable career in ophthalmology. Join us as Dave discusses his journey from leading commercial strategies for billion-dollar brands to mentoring the next generation of innovators. Hear his thoughts on innovation cycles, the evolving landscape of dry eye treatments, and why gene and cell therapies hold the key to ophthalmology’s future. In this episode, you’ll learn: How Dave LeCause helped shape the commercial success of leading ophthalmic brands. H ..read more

In this double-feature episode of the OIS Eye on Innovation Podcast, Carey Powers highlights the invaluable resources and expertise within the OIS community, showcasing the power of cross-collaboration and strategic foresight in biotech. Part 1: Dr. Francis Lasowski (C20/20 Innovation Hub) and Dr. Wendy Naimark (Ripple Therapeutics) discuss their long-standing partnership, which has propelled Ripple's success through groundbreaking innovations, including dry AMD research and key advancements in IP management. Learn how the Innovation Hub provides early-stage companies with critical resources t ..read more

In this episode of The Rob and Jai Show from OIS XIV, hosts Dr. Rob Rothman and Dr. Jai Parekh talk with Eric Schlumpf, CEO of Stuart Therapeutics, about the company’s transformative approach to ophthalmic diseases. Learn how Stuart's innovative polypeptide technology repairs damaged collagen, advancing from dry eye to neuroprotection in glaucoma and beyond. Eric highlights key milestones, including promising clinical trial results, strategic partnerships, and the company’s plans to tackle major unmet needs like myopia and inherited retinal diseases. In this episode, you’ll learn: How Stuart ..read more

Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.   Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include: Alex Lopez, Chief Commercial Officer - ACE Vision Group Hamann Hamadi, MD, PhD, Co-Founder & Chief Medical Officer - Optigo Biotherapeutics Leanne Lavriola, DO, MBA, President & CEO - InnSight Technology ..read more

In this episode, listen in as Dr. Robert Rothman speaks with Dr. Daniel Brocks, CMO of BostonSight! They discuss the unique PROSE lenses that are redefining corneal care and how BostonSight’s nonprofit mission is making advanced treatments accessible to more patients. Key takeaways include: PROSE Lenses: Customized scleral lenses that protect, hydrate, and restore vision for complex eye conditions. Increased Accessibility: BostonSight’s new tech-driven approach to simplify lens fitting for broader use. Mission-Driven Impact: How BostonSight reinvests revenue to offer free care and support for ..read more

In this episode of the OIS Retina Podcast, Firas Rahhal sits down with Jean-Pierre Hubschman, CEO of Horizon Surgical, to discuss the revolutionary advancements in robotic eye surgery. Highlights include: The development of the "IRISS" robotic platform and its focus on cataract surgery. Insights into AI-driven precision, decision-making, and visualization in surgery. Challenges of transitioning from academia to a successful medtech startup. Future potential for robotics in glaucoma, retina, and other ophthalmic procedures. Listen now to hear how AI and robotics are transforming eye surgery ..read more